TSE:NBLY Neighbourly Pharmacy (NBLY) Stock Forecast, Price & News C$12.56 -0.22 (-1.72%) (As of 05:13 PM ET) Add Compare Share Share Today's RangeC$12.50▼C$12.8550-Day RangeC$12.78▼C$18.2452-Week RangeC$12.50▼C$25.50Volume34,240 shsAverage Volume39,178 shsMarket CapitalizationC$561.06 millionP/E RatioN/ADividend Yield1.43%Price TargetC$24.50 ProfileProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlinesSocial MediaProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlinesSocial Media Neighbourly Pharmacy MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside95.1% UpsideC$24.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.06 out of 5 stars 3.3 Analyst's Opinion Consensus RatingNeighbourly Pharmacy has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$24.50, Neighbourly Pharmacy has a forecasted upside of 95.1% from its current price of C$12.56.Amount of Analyst CoverageNeighbourly Pharmacy has only been the subject of 4 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for NBLY. Previous Next 0.8 Dividend Strength Dividend YieldNeighbourly Pharmacy pays a meaningful dividend of 1.28%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNeighbourly Pharmacy does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NBLY. Previous Next 3.0 News and Social Media Coverage News SentimentNeighbourly Pharmacy has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Neighbourly Pharmacy this week, compared to 1 article on an average week.Search Interest2 people have searched for NBLY on MarketBeat in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Neighbourly Pharmacy insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.43% of the stock of Neighbourly Pharmacy is held by insiders.Percentage Held by Institutions70.73% of the stock of Neighbourly Pharmacy is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Neighbourly Pharmacy is -20.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Neighbourly Pharmacy is -20.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeighbourly Pharmacy has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Neighbourly Pharmacy (TSE:NBLY) StockNeighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.Read More NBLY Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NBLY Stock News HeadlinesSeptember 29, 2023 | finance.yahoo.comNeighbourly Recognized as One of Canada's Top Growing Companies in the Globe and Mail's Fifth-Annual RankingSeptember 21, 2023 | americanbankingnews.comNeighbourly Pharmacy Inc. (TSE:NBLY) Given Average Recommendation of "Moderate Buy" by BrokeragesSeptember 29, 2023 | Chaikin Analytics (Ad)Buy This Stock for AI Tidal Wave (not NVDA)The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.September 8, 2023 | finance.yahoo.comWhile individual investors own 27% of Neighbourly Pharmacy Inc. (TSE:NBLY), private equity firms are its largest shareholders with 50% ownershipSeptember 3, 2023 | ca.finance.yahoo.com2 Stocks That Could Beat a Bear MarketAugust 25, 2023 | theglobeandmail.comClosing Bell: Neighbourly Pharmacy Inc flat on Thursday (NBLY)August 5, 2023 | finance.yahoo.comNeighbourly Pharmacy (TSE:NBLY) Has Announced A Dividend Of CA$0.045August 3, 2023 | markets.businessinsider.comRBC Capital Maintains a Buy Rating on Neighbourly Pharmacy, Inc. (NBLY)September 29, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.August 2, 2023 | markets.businessinsider.comBMO Capital Keeps Their Hold Rating on Neighbourly Pharmacy, Inc. (NBLY)August 2, 2023 | finance.yahoo.comNeighbourly Announces Annual Meeting ResultsAugust 1, 2023 | finance.yahoo.comNeighbourly Announces Strong First Quarter ResultsJuly 25, 2023 | finance.yahoo.comNeighbourly Pharmacy Inc. (TSE:NBLY) Is About To Turn The CornerJuly 21, 2023 | finance.yahoo.comNBLY.TO - Neighbourly Pharmacy Inc.July 13, 2023 | markets.businessinsider.comRBC Capital Remains a Buy on Neighbourly Pharmacy, Inc. (NBLY)July 7, 2023 | theglobeandmail.comClosing Bell: Neighbourly Pharmacy Inc up on Thursday (NBLY)July 5, 2023 | ca.finance.yahoo.com1 TSX Bargain Stock I’m Adding to My BasketJune 30, 2023 | finance.yahoo.comFour Days Left Until Neighbourly Pharmacy Inc. (TSE:NBLY) Trades Ex-DividendJune 27, 2023 | finance.yahoo.comNeighbourly: A Friendly Canadian Pharmacy With Value PotentialJune 18, 2023 | finance.yahoo.comStuart Elman Buys Handful Of Shares In Neighbourly PharmacyJune 12, 2023 | theglobeandmail.comClosing Bell: Neighbourly Pharmacy Inc down on Monday (NBLY)June 9, 2023 | msn.comTD SECURITIES Maintains Neighbourly Pharmacy (TSE:NBLY) Buy RecommendationJune 9, 2023 | markets.businessinsider.comNeighbourly Pharmacy, Inc. (NBLY) Gets a Hold Rating from DesjardinsJune 8, 2023 | finance.yahoo.comNeighbourly Announces Strong Fourth Quarter and Full Year ResultsJune 6, 2023 | msn.comNeighbourly agrees to acquire seven pharmacies in Western CanadaJune 6, 2023 | finance.yahoo.comNeighbourly Announces Agreement to Acquire Seven Pharmacies in Western CanadaJune 1, 2023 | finance.yahoo.comNeighbourly Appoints Alicia Matthews-Kent to Lead Pharmacy Strategy and Professional AffairsSee More Headlines Receive NBLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neighbourly Pharmacy and its competitors with MarketBeat's FREE daily newsletter. Email Address NBLY Company Calendar Ex-Dividend for 8/3 Dividend7/05/2023Dividend Payable8/03/2023Ex-Dividend for 9/26 Dividend8/28/2023Dividend Payable9/26/2023Today9/29/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE Industry Pharmaceutical Retailers Sub-IndustryN/A SectorMedical Current SymbolTSE:NBLY CUSIPN/A CIKN/A Webneighbourlypharmacy.ca Phone416 309 9102FaxN/AEmployees3,648Year FoundedN/APrice Target and Rating Average Stock Price ForecastC$24.50 High Stock Price ForecastC$30.00 Low Stock Price ForecastC$20.00 Forecasted Upside/Downside+91.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.61) Trailing P/E RatioN/A Forward P/E Ratio25.12 P/E GrowthN/ANet IncomeC$-26,610,000.00 Net Margins-3.20% Pretax MarginN/A Return on Equity-5.46% Return on Assets0.94% Debt Debt-to-Equity Ratio49.99 Current Ratio1.15 Quick Ratio0.75 Sales & Book Value Annual SalesC$831.61 million Price / Sales0.69 Cash FlowC$0.41 per share Price / Cash Flow31.16 Book ValueC$13.42 per share Price / Book0.95Miscellaneous Outstanding Shares44,670,000Free FloatN/AMarket CapC$570.88 million OptionableNot Optionable Beta0.57 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Skip Bourdo (Age 46)CEO & Director Comp: $604.17kMr. Billy Wong C.M.A.CPA, M.B.A., Chief Financial OfficerMr. Jari Pekka Villanen (Age 52)Sr. VP of Operations Comp: $307.48kMr. Roy J. Wieschkowski (Age 60)Sr. VP of People & Culture Comp: $255.84kMr. Steve Losty (Age 49)Chief Devel. Officer Comp: $302.15kKey CompetitorsExtendicareTSE:EXEKnight TherapeuticsTSE:GUDSienna Senior LivingTSE:SIAAurora CannabisTSE:ACBCRH MedicalTSE:CRHView All CompetitorsInsidersStephen Richard LostySold 22,767 sharesTotal: C$404,489.91 ($17.77/share)Stephen Richard LostySold 13,392 sharesTotal: C$307,608.88 ($22.97/share)View All Insider Transactions NBLY Stock - Frequently Asked Questions Should I buy or sell Neighbourly Pharmacy stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NBLY shares. View NBLY analyst ratings or view top-rated stocks. What is Neighbourly Pharmacy's stock price forecast for 2023? 6 brokerages have issued twelve-month target prices for Neighbourly Pharmacy's shares. Their NBLY share price forecasts range from C$20.00 to C$30.00. On average, they predict the company's stock price to reach C$24.50 in the next year. This suggests a possible upside of 91.7% from the stock's current price. View analysts price targets for NBLY or view top-rated stocks among Wall Street analysts. How have NBLY shares performed in 2023? Neighbourly Pharmacy's stock was trading at C$23.39 at the start of the year. Since then, NBLY shares have decreased by 45.4% and is now trading at C$12.78. View the best growth stocks for 2023 here. How often does Neighbourly Pharmacy pay dividends? What is the dividend yield for Neighbourly Pharmacy? Neighbourly Pharmacy announced a quarterly dividend on Monday, August 28th. Shareholders of record on Tuesday, September 26th will be given a dividend of 0.045 per share on Tuesday, September 26th. This represents a $0.18 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend is Monday, August 28th. Read our dividend analysis for NBLY. Is Neighbourly Pharmacy a good dividend stock? Neighbourly Pharmacy (TSE:NBLY) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 1.28%. Read our dividend analysis for NBLY. What is Neighbourly Pharmacy's stock symbol? Neighbourly Pharmacy trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NBLY." How do I buy shares of Neighbourly Pharmacy? Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Neighbourly Pharmacy's stock price today? One share of NBLY stock can currently be purchased for approximately C$12.78. How much money does Neighbourly Pharmacy make? Neighbourly Pharmacy (TSE:NBLY) has a market capitalization of C$570.88 million and generates C$831.61 million in revenue each year. The company earns C$-26,610,000.00 in net income (profit) each year or C($0.61) on an earnings per share basis. How many employees does Neighbourly Pharmacy have? The company employs 3,648 workers across the globe. How can I contact Neighbourly Pharmacy? Neighbourly Pharmacy's mailing address is 190 Attwell Drive, Unit 400, Toronto, ON M9W 6H8, Canada. The official website for the company is neighbourlypharmacy.ca. The company can be reached via phone at 416 309 9102. This page (TSE:NBLY) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neighbourly Pharmacy Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.